Education
About Us
Working with TipRanks
Follow Us
Nirvana Life Sciences Inc (TSE:NIRV)
:NIRV
Total Valuation
Nirvana Life Sciences Inc has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
Nirvana Life Sciences Inc has 4,545,310 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,545,310
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nirvana Life Sciences Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Nirvana Life Sciences Inc is ―. Nirvana Life Sciences Inc’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Nirvana Life Sciences Inc had revenue of 0.00 and earned ― in profits. Earnings per share was -0.04.
Revenue0.00
Gross Profit0.00
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -252.66K and capital expenditures 0.00, giving a free cash flow of -252.66K billion.
Operating Cash Flow-252.66K
Free Cash Flow-252.66K
Free Cash Flow per Share-0.06
Dividends & Yields
Nirvana Life Sciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.37
52-Week Price Change-50.00%
50-Day Moving Average0.28
200-Day Moving Average0.45
Relative Strength Index (RSI)35.66
Average Volume (3m)858.00
Important Dates
Nirvana Life Sciences Inc upcoming earnings date is Dec 19, 2025, TBA Not Confirmed.
Last Earnings DateApr 8, 2025
Next Earnings DateDec 19, 2025
Ex-Dividend Date―
Financial Position
Nirvana Life Sciences Inc as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Nirvana Life Sciences Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
Nirvana Life Sciences Inc EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Nirvana Life Sciences Inc has C$3.14K in cash and marketable securities with C$323.45K in debt, giving a net cash position of C$20.49K billion.
Cash & Marketable SecuritiesC$3.14K
Total DebtC$323.45K
Net CashC$20.49K
Net Cash Per Share<C$0.01
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Nirvana Life Sciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―